Dreyer T - Search Results

1

Proteolytically generated soluble Tweak Receptor Fn14 is a blood biomarker for γ-secretase activity.

Güner G, Aßfalg M, Zhao K, Dreyer T, Lahiri S, Lo Y, Slivinschi BI, Imhof A, Jocher G, Strohm L, Behrends C, Langosch D, Bronger H, Nimsky C, Bartsch JW, Riddell SR, Steiner H, Lichtenthaler SF. Güner G, et al. Among authors: dreyer t. EMBO Mol Med. 2022 Oct 10;14(10):e16084. doi: 10.15252/emmm.202216084. Epub 2022 Sep 7. EMBO Mol Med. 2022. PMID: 36069059 Free PMC article.

2

Induction of cathepsin B by the CXCR3 chemokines CXCL9 and CXCL10 in human breast cancer cells.

Bronger H, Karge A, Dreyer T, Zech D, Kraeft S, Avril S, Kiechle M, Schmitt M. Bronger H, et al. Among authors: dreyer t. Oncol Lett. 2017 Jun;13(6):4224-4230. doi: 10.3892/ol.2017.5994. Epub 2017 Apr 5. Oncol Lett. 2017. PMID: 28599423 Free PMC article.

3

Prognosis of ovarian cancer is associated with effector memory CD8⁺ T cell accumulation in ascites, CXCL9 levels and activation-triggered signal transduction in T cells.

Lieber S, Reinartz S, Raifer H, Finkernagel F, Dreyer T, Bronger H, Jansen JM, Wagner U, Worzfeld T, Müller R, Huber M. Lieber S, et al. Among authors: dreyer t. Oncoimmunology. 2018 Mar 15;7(5):e1424672. doi: 10.1080/2162402X.2018.1424672. eCollection 2018. Oncoimmunology. 2018. PMID: 29721385 Free PMC article.

4

Elevated tumor tissue protein expression levels of kallikrein-related peptidases KLK10 and KLK11 are associated with a better prognosis in advanced high-grade serous ovarian cancer patients.

Geng X, Liu Y, Dreyer T, Bronger H, Drecoll E, Magdolen V, Dorn J. Geng X, et al. Among authors: dreyer t. Am J Cancer Res. 2018 Sep 1;8(9):1856-1864. eCollection 2018. Am J Cancer Res. 2018. PMID: 30323977 Free PMC article.

5

Characterization of kallikrein-related peptidase 4 (KLK4) mRNA expression in tumor tissue of advanced high-grade serous ovarian cancer patients.

Gong W, Liu Y, Seidl C, Dreyer T, Drecoll E, Kotzsch M, Bronger H, Dorn J, Magdolen V. Gong W, et al. Among authors: dreyer t. PLoS One. 2019 Feb 27;14(2):e0212968. doi: 10.1371/journal.pone.0212968. eCollection 2019. PLoS One. 2019. PMID: 30811511 Free PMC article.

6

Proteolytic chemokine cleavage as a regulator of lymphocytic infiltration in solid tumors.

Bronger H, Magdolen V, Goettig P, Dreyer T. Bronger H, et al. Among authors: dreyer t. Cancer Metastasis Rev. 2019 Sep;38(3):417-430. doi: 10.1007/s10555-019-09807-3. Cancer Metastasis Rev. 2019. PMID: 31482487 Free PMC article. Review.

7

High levels of KLK7 protein expression are related to a favorable prognosis in triple-negative breast cancer patients.

Geng X, Babayeva L, Walch A, Aubele M, Groß E, Kiechle M, Bronger H, Dreyer T, Magdolen V, Dorn J. Geng X, et al. Among authors: dreyer t. Am J Cancer Res. 2020 Jun 1;10(6):1785-1792. eCollection 2020. Am J Cancer Res. 2020. PMID: 32642290 Free PMC article.

8

Prognostic value of kallikrein-related peptidase 7 (KLK7) mRNA expression in advanced high-grade serous ovarian cancer.

Gong W, Liu Y, Diamandis EP, Kiechle M, Bronger H, Dorn J, Dreyer T, Magdolen V. Gong W, et al. Among authors: dreyer t. J Ovarian Res. 2020 Oct 21;13(1):125. doi: 10.1186/s13048-020-00725-5. J Ovarian Res. 2020. PMID: 33087135 Free PMC article.

9

Elevated levels of both microRNA 378 (miR-378) and kallikrein-related peptidase 4 (KLK4) mRNA are associated with an unfavorable prognosis in triple-negative breast cancer.

Gong W, Zhu C, Liu Y, Muckenhuber A, Bronger H, Scorilas A, Kiechle M, Dorn J, Magdolen V, Dreyer T. Gong W, et al. Among authors: dreyer t. Am J Transl Res. 2021 Mar 15;13(3):1594-1606. eCollection 2021. Am J Transl Res. 2021. PMID: 33841682 Free PMC article.

10

The Chemokine CX3CL1 Improves Trastuzumab Efficacy in HER2 Low-Expressing Cancer In Vitro and In Vivo.

Dreyer TF, Kuhn S, Stange C, Heithorst N, Schilling D, Jelsma J, Sievert W, Seitz S, Stangl S, Hapfelmeier A, Noske A, Wege AK, Weichert W, Ruland J, Schmitt M, Dorn J, Kiechle M, Reuning U, Magdolen V, Multhoff G, Bronger H. Dreyer TF, et al. Cancer Immunol Res. 2021 Jul;9(7):779-789. doi: 10.1158/2326-6066.CIR-20-0327. Epub 2021 Apr 27. Cancer Immunol Res. 2021. PMID: 33906866

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

333 results

Search Page

Filters